
Jeffrey T. Palenik
Examiner (ID: 8947, Phone: (571)270-1966 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 1192 |
| Issued Applications | 644 |
| Pending Applications | 99 |
| Abandoned Applications | 467 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18433470
[patent_doc_number] => 20230180764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => THREE-DIMENSIONALLY PRINTABLE ANTIVIRAL FILAMENT
[patent_app_type] => utility
[patent_app_number] => 17/997414
[patent_app_country] => US
[patent_app_date] => 2021-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997414
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997414 | THREE-DIMENSIONALLY PRINTABLE ANTIVIRAL FILAMENT | Apr 25, 2021 | Pending |
Array
(
[id] => 17198627
[patent_doc_number] => 20210338721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => BIOAVAILABLE MINERALS FOR THE MITIGATION OF PATHOGENS IN ANIMALS, A MANUFACTURING METHOD AND A TREATMENT METHOD
[patent_app_type] => utility
[patent_app_number] => 17/237477
[patent_app_country] => US
[patent_app_date] => 2021-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6963
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17237477
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/237477 | BIOAVAILABLE MINERALS FOR THE MITIGATION OF PATHOGENS IN ANIMALS, A MANUFACTURING METHOD AND A TREATMENT METHOD | Apr 21, 2021 | Abandoned |
Array
(
[id] => 21009765
[patent_doc_number] => 12746236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-09-29
[patent_title] => Quinine and its use to generate innate immune response
[patent_app_type] => utility
[patent_app_number] => 17/996853
[patent_app_country] => US
[patent_app_date] => 2021-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 15
[patent_no_of_words] => 5522
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996853
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996853 | QUININE AND ITS USE TO GENERATE INNATE IMMUNE RESPONSE | Apr 20, 2021 | Pending |
Array
(
[id] => 17799056
[patent_doc_number] => 11413323
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Ophthalmic composition for treatment of dry eye disease
[patent_app_type] => utility
[patent_app_number] => 17/228309
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 22274
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17228309
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/228309 | Ophthalmic composition for treatment of dry eye disease | Apr 11, 2021 | Issued |
Array
(
[id] => 20356225
[patent_doc_number] => 12472204
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => Compound of element acid, which is in allotropic form, which enters into cellular interaction in some bone diseases
[patent_app_type] => utility
[patent_app_number] => 18/269291
[patent_app_country] => US
[patent_app_date] => 2021-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 0
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18269291
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/269291 | Compound of element acid, which is in allotropic form, which enters into cellular interaction in some bone diseases | Apr 4, 2021 | Issued |
Array
(
[id] => 17895361
[patent_doc_number] => 20220305023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => Chlorophyllin Containing Pharmaceutical Composition For Prevention Of Pathogenesis Of Coronavirus Disease
[patent_app_type] => utility
[patent_app_number] => 17/214450
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17214450
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/214450 | Chlorophyllin Containing Pharmaceutical Composition For Prevention Of Pathogenesis Of Coronavirus Disease | Mar 25, 2021 | Abandoned |
Array
(
[id] => 19157626
[patent_doc_number] => 20240150333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => TAF1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/913033
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29391
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17913033
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/913033 | TAF1 INHIBITORS | Mar 21, 2021 | Pending |
Array
(
[id] => 17035083
[patent_doc_number] => 20210252041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => COMPOSITIONS AND METHODS FOR APPLICATION OVER SKIN
[patent_app_type] => utility
[patent_app_number] => 17/198629
[patent_app_country] => US
[patent_app_date] => 2021-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39844
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17198629
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/198629 | COMPOSITIONS AND METHODS FOR APPLICATION OVER SKIN | Mar 10, 2021 | Pending |
Array
(
[id] => 17576770
[patent_doc_number] => 20220133625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => METHOD FOR ELIMINATING SPECIFIC PATHOGENIC MICROORGANISMS IN THE BODY
[patent_app_type] => utility
[patent_app_number] => 17/182664
[patent_app_country] => US
[patent_app_date] => 2021-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 225
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182664
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/182664 | METHOD FOR ELIMINATING SPECIFIC PATHOGENIC MICROORGANISMS IN THE BODY | Feb 22, 2021 | Abandoned |
Array
(
[id] => 16869841
[patent_doc_number] => 20210163308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => COMPOSITIONS AND METHODS FOR THE MODULATION OF CYTOKINES
[patent_app_type] => utility
[patent_app_number] => 17/176728
[patent_app_country] => US
[patent_app_date] => 2021-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176728
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/176728 | COMPOSITIONS AND METHODS FOR THE MODULATION OF CYTOKINES | Feb 15, 2021 | Abandoned |
Array
(
[id] => 16899101
[patent_doc_number] => 20210178017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => MULTI-LAYER BIOMATERIAL FOR TISSUE REGENERATION AND WOUND HEALING
[patent_app_type] => utility
[patent_app_number] => 17/169195
[patent_app_country] => US
[patent_app_date] => 2021-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19585
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -59
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169195
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/169195 | MULTI-LAYER BIOMATERIAL FOR TISSUE REGENERATION AND WOUND HEALING | Feb 4, 2021 | Pending |
Array
(
[id] => 20239602
[patent_doc_number] => 12419906
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-23
[patent_title] => Compositions and methods for application over skin
[patent_app_type] => utility
[patent_app_number] => 17/144379
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 34980
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17144379
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/144379 | Compositions and methods for application over skin | Jan 7, 2021 | Issued |
Array
(
[id] => 18398197
[patent_doc_number] => 11660313
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-30
[patent_title] => Compositions and methods for application over skin
[patent_app_type] => utility
[patent_app_number] => 17/139268
[patent_app_country] => US
[patent_app_date] => 2020-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 39831
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17139268
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/139268 | Compositions and methods for application over skin | Dec 30, 2020 | Issued |
Array
(
[id] => 18196378
[patent_doc_number] => 20230049897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => DOSAGE REGIME WITH ESKETAMINE FOR TREATING NEUROPSYCHIATRIC OR NEUROLOGICAL CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/789648
[patent_app_country] => US
[patent_app_date] => 2020-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21230
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789648
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/789648 | Dosage regime with esketamine for treating neuropsychiatric or neurological conditions | Dec 28, 2020 | Issued |
Array
(
[id] => 18503572
[patent_doc_number] => 11701362
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-18
[patent_title] => Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1- methylcyclohexane-1-carboxamide
[patent_app_type] => utility
[patent_app_number] => 17/129945
[patent_app_country] => US
[patent_app_date] => 2020-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 60
[patent_no_of_words] => 25054
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 227
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17129945
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/129945 | Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1- methylcyclohexane-1-carboxamide | Dec 21, 2020 | Issued |
Array
(
[id] => 18164836
[patent_doc_number] => 20230031433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => COMPOSITIONS AND METHODS FOR MANAGING INFECTIONS OF A URINARY TRACT
[patent_app_type] => utility
[patent_app_number] => 17/784157
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12933
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17784157
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/784157 | COMPOSITIONS AND METHODS FOR MANAGING INFECTIONS OF A URINARY TRACT | Dec 17, 2020 | Abandoned |
Array
(
[id] => 18706809
[patent_doc_number] => 20230329381
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2023-10-19
[patent_title] => Eyelash Extension Adhesive
[patent_app_type] => utility
[patent_app_number] => 17/785202
[patent_app_country] => US
[patent_app_date] => 2020-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5363
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17785202
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/785202 | Eyelash extension adhesive | Dec 10, 2020 | Issued |
Array
(
[id] => 18706809
[patent_doc_number] => 20230329381
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2023-10-19
[patent_title] => Eyelash Extension Adhesive
[patent_app_type] => utility
[patent_app_number] => 17/785202
[patent_app_country] => US
[patent_app_date] => 2020-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5363
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17785202
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/785202 | Eyelash extension adhesive | Dec 10, 2020 | Issued |
Array
(
[id] => 16726514
[patent_doc_number] => 20210093661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => COMPOSITIONS OF AND METHODS FOR DAIRY ANIMAL TEAT DIP
[patent_app_type] => utility
[patent_app_number] => 17/117790
[patent_app_country] => US
[patent_app_date] => 2020-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3679
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -111
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17117790
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/117790 | Compositions of and methods for dairy animal teat dip | Dec 9, 2020 | Issued |
Array
(
[id] => 16720195
[patent_doc_number] => 20210087342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => POLYPHOSPHAZENE POLYELECTROLYTES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/111043
[patent_app_country] => US
[patent_app_date] => 2020-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7847
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17111043
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/111043 | Polyphosphazene polyelectrolytes and uses thereof | Dec 2, 2020 | Issued |